JP2009221205A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009221205A5 JP2009221205A5 JP2009110392A JP2009110392A JP2009221205A5 JP 2009221205 A5 JP2009221205 A5 JP 2009221205A5 JP 2009110392 A JP2009110392 A JP 2009110392A JP 2009110392 A JP2009110392 A JP 2009110392A JP 2009221205 A5 JP2009221205 A5 JP 2009221205A5
- Authority
- JP
- Japan
- Prior art keywords
- indole
- carboxamide
- morpholin
- sulfonyl
- bromo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000753 cycloalkyl group Chemical group 0.000 claims 17
- 125000003118 aryl group Chemical group 0.000 claims 14
- 125000000623 heterocyclic group Chemical group 0.000 claims 14
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims 14
- 125000000217 alkyl group Chemical group 0.000 claims 10
- -1 (aminocarbonyl) -3- (morpholin-4-ylsulfonyl) -1H-indole-5-carboxylate Chemical compound 0.000 claims 8
- 150000001875 compounds Chemical class 0.000 claims 8
- 229910052736 halogen Inorganic materials 0.000 claims 8
- 150000002367 halogens Chemical class 0.000 claims 8
- 125000001424 substituent group Chemical group 0.000 claims 7
- HRDXJKGNWSUIBT-UHFFFAOYSA-N methoxybenzene Chemical group [CH2]OC1=CC=CC=C1 HRDXJKGNWSUIBT-UHFFFAOYSA-N 0.000 claims 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 4
- AOEOFSMAYKZDGD-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-(2,3-dihydro-1h-inden-1-yl)morpholine-2-carboxamide Chemical compound C1CC2=CC=CC=C2C1NC(=O)C(C1)OCCN1S(=O)(=O)C1=C(C(=O)N)NC2=CC=C(Br)C=C21 AOEOFSMAYKZDGD-UHFFFAOYSA-N 0.000 claims 3
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims 3
- BKIMMITUMNQMOS-UHFFFAOYSA-N normal nonane Natural products CCCCCCCCC BKIMMITUMNQMOS-UHFFFAOYSA-N 0.000 claims 3
- 125000003107 substituted aryl group Chemical group 0.000 claims 3
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 2
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 2
- 125000003342 alkenyl group Chemical group 0.000 claims 2
- 125000000304 alkynyl group Chemical group 0.000 claims 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 2
- ISMBKJOFRDHUEK-UHFFFAOYSA-N (2-carbamoyl-3-morpholin-4-ylsulfonyl-1h-indol-5-yl) methanesulfonate Chemical compound C12=CC(OS(=O)(=O)C)=CC=C2NC(C(N)=O)=C1S(=O)(=O)N1CCOCC1 ISMBKJOFRDHUEK-UHFFFAOYSA-N 0.000 claims 1
- YEHZLTRBZWGIKK-UHFFFAOYSA-N 1-morpholin-4-ylsulfonylindole-2-carboxamide Chemical compound NC(=O)C1=CC2=CC=CC=C2N1S(=O)(=O)N1CCOCC1 YEHZLTRBZWGIKK-UHFFFAOYSA-N 0.000 claims 1
- JBCWXEDCYISNIJ-UHFFFAOYSA-N 3-(3-benzylpiperidin-1-yl)sulfonyl-5-chloro-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Cl)C=C2C=1S(=O)(=O)N(C1)CCCC1CC1=CC=CC=C1 JBCWXEDCYISNIJ-UHFFFAOYSA-N 0.000 claims 1
- RRFUFVAFDHNUSM-UHFFFAOYSA-N 3-(3-hydroxyazetidin-1-yl)sulfonyl-5-iodo-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(I)C=C2C=1S(=O)(=O)N1CC(O)C1 RRFUFVAFDHNUSM-UHFFFAOYSA-N 0.000 claims 1
- NVJJBPAWEMXLMX-UHFFFAOYSA-N 3-(4-acetylpiperazin-1-yl)sulfonyl-5-chloro-1h-indole-2-carboxamide Chemical compound C1CN(C(=O)C)CCN1S(=O)(=O)C1=C(C(N)=O)NC2=CC=C(Cl)C=C12 NVJJBPAWEMXLMX-UHFFFAOYSA-N 0.000 claims 1
- JWQGLPQMPIWPKQ-UHFFFAOYSA-N 3-(4-benzylpiperazin-1-yl)sulfonyl-5-chloro-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Cl)C=C2C=1S(=O)(=O)N(CC1)CCN1CC1=CC=CC=C1 JWQGLPQMPIWPKQ-UHFFFAOYSA-N 0.000 claims 1
- XAQDXLCTHDKRAI-UHFFFAOYSA-N 3-(azetidin-1-ylsulfonyl)-5-bromo-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N1CCC1 XAQDXLCTHDKRAI-UHFFFAOYSA-N 0.000 claims 1
- CQIBAQUOQBVTGN-UHFFFAOYSA-N 3-(azetidin-1-ylsulfonyl)-5-chloro-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Cl)C=C2C=1S(=O)(=O)N1CCC1 CQIBAQUOQBVTGN-UHFFFAOYSA-N 0.000 claims 1
- RBLJXUJZGKQZPF-UHFFFAOYSA-N 3-(azetidin-1-ylsulfonyl)-5-methoxy-1h-indole-2-carboxamide Chemical compound C12=CC(OC)=CC=C2NC(C(N)=O)=C1S(=O)(=O)N1CCC1 RBLJXUJZGKQZPF-UHFFFAOYSA-N 0.000 claims 1
- OVBCPNXFQRHAMT-FQEVSTJZSA-N 3-[(2s)-2-(phenoxymethyl)morpholin-4-yl]sulfonyl-7-(pyridin-4-ylmethylamino)-1h-indole-2-carboxamide Chemical compound C1=CC=C2C(S(=O)(=O)N3C[C@@H](COC=4C=CC=CC=4)OCC3)=C(C(=O)N)NC2=C1NCC1=CC=NC=C1 OVBCPNXFQRHAMT-FQEVSTJZSA-N 0.000 claims 1
- IYHAQCNPVUXRAI-UHFFFAOYSA-N 3-[(3-benzyl-1-oxa-8-azaspiro[4.5]decan-8-yl)sulfonyl]-5-chloro-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Cl)C=C2C=1S(=O)(=O)N(CC1)CCC1(OC1)CC1CC1=CC=CC=C1 IYHAQCNPVUXRAI-UHFFFAOYSA-N 0.000 claims 1
- KZHRPFUTQSSJBE-UHFFFAOYSA-N 3-[(7-benzyl-2,7-diazaspiro[4.4]nonan-2-yl)sulfonyl]-5-bromo-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N(C1)CCC1(C1)CCN1CC1=CC=CC=C1 KZHRPFUTQSSJBE-UHFFFAOYSA-N 0.000 claims 1
- MUGUDMNLPFNAQF-UHFFFAOYSA-N 3-[2-(3-benzylpyrrolidine-1-carbonyl)morpholin-4-yl]sulfonyl-5-bromo-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N(C1)CCOC1C(=O)N(C1)CCC1CC1=CC=CC=C1 MUGUDMNLPFNAQF-UHFFFAOYSA-N 0.000 claims 1
- MTYRLPSQQNKYAS-UHFFFAOYSA-N 3-[2-(4-benzylpiperazine-1-carbonyl)morpholin-4-yl]sulfonyl-5-bromo-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N(C1)CCOC1C(=O)N(CC1)CCN1CC1=CC=CC=C1 MTYRLPSQQNKYAS-UHFFFAOYSA-N 0.000 claims 1
- MBRUGKWBJSTANX-UHFFFAOYSA-N 3-[2-(azepane-1-carbonyl)morpholin-4-yl]sulfonyl-5-bromo-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N(C1)CCOC1C(=O)N1CCCCCC1 MBRUGKWBJSTANX-UHFFFAOYSA-N 0.000 claims 1
- WGNVYVFZSJTMSZ-UHFFFAOYSA-N 3-[2-[2-(1,3-benzothiazol-2-yl)pyrrolidine-1-carbonyl]morpholin-4-yl]sulfonyl-5-bromo-1h-indole-2-carboxamide Chemical compound C1=CC=C2SC(C3CCCN3C(=O)C3OCCN(C3)S(=O)(=O)C=3C4=CC(Br)=CC=C4NC=3C(=O)N)=NC2=C1 WGNVYVFZSJTMSZ-UHFFFAOYSA-N 0.000 claims 1
- NOKGMVYVOHQJRT-UHFFFAOYSA-N 3-[[2-(1-benzofuran-2-yl)-1-oxa-8-azaspiro[4.5]decan-8-yl]sulfonyl]-5-chloro-1h-indole-2-carboxamide Chemical compound C1=CC=C2OC(C3CCC4(CCN(CC4)S(=O)(=O)C=4C5=CC(Cl)=CC=C5NC=4C(=O)N)O3)=CC2=C1 NOKGMVYVOHQJRT-UHFFFAOYSA-N 0.000 claims 1
- TZKCGGDSNIAOTN-UHFFFAOYSA-N 3-morpholin-4-ylsulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=CC=C2C=1S(=O)(=O)N1CCOCC1 TZKCGGDSNIAOTN-UHFFFAOYSA-N 0.000 claims 1
- JAZVOBCHQUTMDH-UHFFFAOYSA-N 3-morpholin-4-ylsulfonyl-5-(1,3-thiazol-2-yl)-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(C=3SC=CN=3)C=C2C=1S(=O)(=O)N1CCOCC1 JAZVOBCHQUTMDH-UHFFFAOYSA-N 0.000 claims 1
- KAGBSOQIBBXENC-UHFFFAOYSA-N 3-morpholin-4-ylsulfonyl-5-(1h-pyrrol-2-yl)-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(C=3NC=CC=3)C=C2C=1S(=O)(=O)N1CCOCC1 KAGBSOQIBBXENC-UHFFFAOYSA-N 0.000 claims 1
- RQSZDLAFSUUHRP-UHFFFAOYSA-N 3-morpholin-4-ylsulfonyl-5-(2-phenylethyl)-1h-indole-2-carboxamide Chemical compound C1=C2C(S(=O)(=O)N3CCOCC3)=C(C(=O)N)NC2=CC=C1CCC1=CC=CC=C1 RQSZDLAFSUUHRP-UHFFFAOYSA-N 0.000 claims 1
- XTZHLPUTPHINGK-UHFFFAOYSA-N 3-morpholin-4-ylsulfonyl-5-(2-phenylethynyl)-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(C#CC=3C=CC=CC=3)C=C2C=1S(=O)(=O)N1CCOCC1 XTZHLPUTPHINGK-UHFFFAOYSA-N 0.000 claims 1
- SLGNPJAIDFICGP-UHFFFAOYSA-N 3-morpholin-4-ylsulfonyl-5-[(2,2,2-trifluoroacetyl)amino]-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(NC(=O)C(F)(F)F)C=C2C=1S(=O)(=O)N1CCOCC1 SLGNPJAIDFICGP-UHFFFAOYSA-N 0.000 claims 1
- ATJXRQUNMXDJBI-UHFFFAOYSA-N 3-morpholin-4-ylsulfonyl-5-nitro-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C([N+]([O-])=O)C=C2C=1S(=O)(=O)N1CCOCC1 ATJXRQUNMXDJBI-UHFFFAOYSA-N 0.000 claims 1
- IVKJJTLXSYYIAB-UHFFFAOYSA-N 3-morpholin-4-ylsulfonyl-5-propan-2-yloxy-1h-indole-2-carboxamide Chemical compound C12=CC(OC(C)C)=CC=C2NC(C(N)=O)=C1S(=O)(=O)N1CCOCC1 IVKJJTLXSYYIAB-UHFFFAOYSA-N 0.000 claims 1
- JXFWMXQWUGXFTD-UHFFFAOYSA-N 3-morpholin-4-ylsulfonyl-5-propoxy-1h-indole-2-carboxamide Chemical compound C12=CC(OCCC)=CC=C2NC(C(N)=O)=C1S(=O)(=O)N1CCOCC1 JXFWMXQWUGXFTD-UHFFFAOYSA-N 0.000 claims 1
- FNMGVDUOBJKKAX-UHFFFAOYSA-N 3-morpholin-4-ylsulfonyl-5-pyridin-3-yl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(C=3C=NC=CC=3)C=C2C=1S(=O)(=O)N1CCOCC1 FNMGVDUOBJKKAX-UHFFFAOYSA-N 0.000 claims 1
- OLYOEGWFUNWSMF-UHFFFAOYSA-N 3-morpholin-4-ylsulfonyl-5-thiophen-2-yl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(C=3SC=CC=3)C=C2C=1S(=O)(=O)N1CCOCC1 OLYOEGWFUNWSMF-UHFFFAOYSA-N 0.000 claims 1
- ZBLWFCIIHLPMKI-UHFFFAOYSA-N 3-morpholin-4-ylsulfonyl-5-thiophen-3-yl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(C3=CSC=C3)C=C2C=1S(=O)(=O)N1CCOCC1 ZBLWFCIIHLPMKI-UHFFFAOYSA-N 0.000 claims 1
- JVRRGJZWNZDGEX-UHFFFAOYSA-N 3-morpholin-4-ylsulfonyl-7-(pyridin-4-ylmethylamino)-1h-indole-2-carboxamide Chemical compound C1=CC=C2C(S(=O)(=O)N3CCOCC3)=C(C(=O)N)NC2=C1NCC1=CC=NC=C1 JVRRGJZWNZDGEX-UHFFFAOYSA-N 0.000 claims 1
- HBFXUOQPARKSLD-UHFFFAOYSA-N 4,5-dibromo-3-morpholin-4-ylsulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C(Br)=C2C=1S(=O)(=O)N1CCOCC1 HBFXUOQPARKSLD-UHFFFAOYSA-N 0.000 claims 1
- BEKHKDNSGSMOQK-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-(1,2,3,4-tetrahydronaphthalen-2-ylmethyl)morpholine-2-carboxamide Chemical compound C1CC2=CC=CC=C2CC1CNC(=O)C(C1)OCCN1S(=O)(=O)C1=C(C(=O)N)NC2=CC=C(Br)C=C21 BEKHKDNSGSMOQK-UHFFFAOYSA-N 0.000 claims 1
- QRDUEQGKMQDVHK-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-(1,2-diphenylethyl)morpholine-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N(C1)CCOC1C(=O)NC(C=1C=CC=CC=1)CC1=CC=CC=C1 QRDUEQGKMQDVHK-UHFFFAOYSA-N 0.000 claims 1
- GCDSRNUXMDFBAE-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-(1,4-dioxan-2-ylmethyl)morpholine-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N(C1)CCOC1C(=O)NCC1COCCO1 GCDSRNUXMDFBAE-UHFFFAOYSA-N 0.000 claims 1
- QVMASHOLPSONNC-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-(1-methoxypropan-2-yl)morpholine-2-carboxamide Chemical compound C1COC(C(=O)NC(C)COC)CN1S(=O)(=O)C1=C(C(N)=O)NC2=CC=C(Br)C=C12 QVMASHOLPSONNC-UHFFFAOYSA-N 0.000 claims 1
- OLGQPWOWVIAAPM-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-(1-phenylcyclopropyl)morpholine-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N(C1)CCOC1C(=O)NC1(C=2C=CC=CC=2)CC1 OLGQPWOWVIAAPM-UHFFFAOYSA-N 0.000 claims 1
- UNCPTNYTGPWAMP-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-(1-phenylethyl)morpholine-2-carboxamide Chemical compound C1N(S(=O)(=O)C=2C3=CC(Br)=CC=C3NC=2C(N)=O)CCOC1C(=O)NC(C)C1=CC=CC=C1 UNCPTNYTGPWAMP-UHFFFAOYSA-N 0.000 claims 1
- YHJLTYHTFZRTKT-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-(2,2,3,3,4,4,4-heptafluorobutyl)morpholine-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N1CCOC(C(=O)NCC(F)(F)C(F)(F)C(F)(F)F)C1 YHJLTYHTFZRTKT-UHFFFAOYSA-N 0.000 claims 1
- HRZSMWWNOKJDTJ-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-(2,2-dimethylpropyl)morpholine-2-carboxamide Chemical compound C1COC(C(=O)NCC(C)(C)C)CN1S(=O)(=O)C1=C(C(N)=O)NC2=CC=C(Br)C=C12 HRZSMWWNOKJDTJ-UHFFFAOYSA-N 0.000 claims 1
- XXCNDMSBINMSHM-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-(2,2-diphenylethyl)morpholine-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N(C1)CCOC1C(=O)NCC(C=1C=CC=CC=1)C1=CC=CC=C1 XXCNDMSBINMSHM-UHFFFAOYSA-N 0.000 claims 1
- KIYKWWQRXUTRAX-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-(2,3-dihydro-1h-inden-2-yl)morpholine-2-carboxamide Chemical compound C1C2=CC=CC=C2CC1NC(=O)C(C1)OCCN1S(=O)(=O)C1=C(C(=O)N)NC2=CC=C(Br)C=C21 KIYKWWQRXUTRAX-UHFFFAOYSA-N 0.000 claims 1
- LUYGRYORWWMEGW-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-(2,3-dihydro-1h-inden-2-ylmethyl)morpholine-2-carboxamide Chemical compound C1C2=CC=CC=C2CC1CNC(=O)C(C1)OCCN1S(=O)(=O)C1=C(C(=O)N)NC2=CC=C(Br)C=C21 LUYGRYORWWMEGW-UHFFFAOYSA-N 0.000 claims 1
- MEZZWFFSYZTZCL-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-(2-cyclohexylethyl)morpholine-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N(C1)CCOC1C(=O)NCCC1CCCCC1 MEZZWFFSYZTZCL-UHFFFAOYSA-N 0.000 claims 1
- JKKMPNLSOMOXHT-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-(2-hydroxy-2,3-dihydro-1h-inden-1-yl)morpholine-2-carboxamide Chemical compound OC1CC2=CC=CC=C2C1NC(=O)C(C1)OCCN1S(=O)(=O)C1=C(C(=O)N)NC2=CC=C(Br)C=C21 JKKMPNLSOMOXHT-UHFFFAOYSA-N 0.000 claims 1
- AFJICAGJZCKIQI-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-(2-methoxyethyl)morpholine-2-carboxamide Chemical compound C1COC(C(=O)NCCOC)CN1S(=O)(=O)C1=C(C(N)=O)NC2=CC=C(Br)C=C12 AFJICAGJZCKIQI-UHFFFAOYSA-N 0.000 claims 1
- FYKJZHWCPYKVNH-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-(2-phenoxyethyl)morpholine-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N(C1)CCOC1C(=O)NCCOC1=CC=CC=C1 FYKJZHWCPYKVNH-UHFFFAOYSA-N 0.000 claims 1
- PSABPMJAXRYHNY-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-(2-phenylethyl)morpholine-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N(C1)CCOC1C(=O)NCCC1=CC=CC=C1 PSABPMJAXRYHNY-UHFFFAOYSA-N 0.000 claims 1
- DRHSSMHDIUWMQV-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-(2-phenylpropyl)morpholine-2-carboxamide Chemical compound C1N(S(=O)(=O)C=2C3=CC(Br)=CC=C3NC=2C(N)=O)CCOC1C(=O)NCC(C)C1=CC=CC=C1 DRHSSMHDIUWMQV-UHFFFAOYSA-N 0.000 claims 1
- OIHLRPAXOLPGTO-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-(2-tert-butylsulfanylethyl)morpholine-2-carboxamide Chemical compound C1COC(C(=O)NCCSC(C)(C)C)CN1S(=O)(=O)C1=C(C(N)=O)NC2=CC=C(Br)C=C12 OIHLRPAXOLPGTO-UHFFFAOYSA-N 0.000 claims 1
- PQGCABIODIKPGG-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-(2-thiophen-2-ylethyl)morpholine-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N(C1)CCOC1C(=O)NCCC1=CC=CS1 PQGCABIODIKPGG-UHFFFAOYSA-N 0.000 claims 1
- ZPZVLHPFKFKCKP-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-(3,3-diphenylpropyl)morpholine-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N(C1)CCOC1C(=O)NCCC(C=1C=CC=CC=1)C1=CC=CC=C1 ZPZVLHPFKFKCKP-UHFFFAOYSA-N 0.000 claims 1
- CWXWNCLWOHMQDB-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-(3-butoxypropyl)morpholine-2-carboxamide Chemical compound C1COC(C(=O)NCCCOCCCC)CN1S(=O)(=O)C1=C(C(N)=O)NC2=CC=C(Br)C=C12 CWXWNCLWOHMQDB-UHFFFAOYSA-N 0.000 claims 1
- BQZCJIMIKBYSPZ-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-(3-ethoxypropyl)morpholine-2-carboxamide Chemical compound C1COC(C(=O)NCCCOCC)CN1S(=O)(=O)C1=C(C(N)=O)NC2=CC=C(Br)C=C12 BQZCJIMIKBYSPZ-UHFFFAOYSA-N 0.000 claims 1
- YJYFXJULLKSRSO-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-(3-imidazol-1-ylpropyl)morpholine-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N(C1)CCOC1C(=O)NCCCN1C=CN=C1 YJYFXJULLKSRSO-UHFFFAOYSA-N 0.000 claims 1
- GGJSXYCPRSXNJB-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-(3-phenylpropyl)morpholine-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N(C1)CCOC1C(=O)NCCCC1=CC=CC=C1 GGJSXYCPRSXNJB-UHFFFAOYSA-N 0.000 claims 1
- WCAOVZIGZXQSPR-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-(3-propan-2-yloxypropyl)morpholine-2-carboxamide Chemical compound C1COC(C(=O)NCCCOC(C)C)CN1S(=O)(=O)C1=C(C(N)=O)NC2=CC=C(Br)C=C12 WCAOVZIGZXQSPR-UHFFFAOYSA-N 0.000 claims 1
- SCCXJOZZOVEEBA-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-(4-chlorophenyl)morpholine-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N(C1)CCOC1C(=O)NC1=CC=C(Cl)C=C1 SCCXJOZZOVEEBA-UHFFFAOYSA-N 0.000 claims 1
- NQUQDMPBXAZBQU-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-(4-phenoxyphenyl)morpholine-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N(C1)CCOC1C(=O)NC(C=C1)=CC=C1OC1=CC=CC=C1 NQUQDMPBXAZBQU-UHFFFAOYSA-N 0.000 claims 1
- MZLFMCGFHZPANE-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-(4-tert-butylphenyl)morpholine-2-carboxamide Chemical compound C1=CC(C(C)(C)C)=CC=C1NC(=O)C1OCCN(S(=O)(=O)C=2C3=CC(Br)=CC=C3NC=2C(N)=O)C1 MZLFMCGFHZPANE-UHFFFAOYSA-N 0.000 claims 1
- VMFIOKRYHYYTAT-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-(dicyclopropylmethyl)morpholine-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N(C1)CCOC1C(=O)NC(C1CC1)C1CC1 VMFIOKRYHYYTAT-UHFFFAOYSA-N 0.000 claims 1
- KXNLCKUFKSKGGR-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-(naphthalen-1-ylmethyl)morpholine-2-carboxamide Chemical compound C1=CC=C2C(CNC(=O)C3OCCN(C3)S(=O)(=O)C=3C4=CC(Br)=CC=C4NC=3C(=O)N)=CC=CC2=C1 KXNLCKUFKSKGGR-UHFFFAOYSA-N 0.000 claims 1
- YTMVSMGFNTUOSY-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-(oxolan-2-ylmethyl)morpholine-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N(C1)CCOC1C(=O)NCC1CCCO1 YTMVSMGFNTUOSY-UHFFFAOYSA-N 0.000 claims 1
- GICAPNSKOZJDEY-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-(pyridin-2-ylmethyl)morpholine-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N(C1)CCOC1C(=O)NCC1=CC=CC=N1 GICAPNSKOZJDEY-UHFFFAOYSA-N 0.000 claims 1
- MNUAQKNPJNWLKS-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-(pyridin-3-ylmethyl)morpholine-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N(C1)CCOC1C(=O)NCC1=CC=CN=C1 MNUAQKNPJNWLKS-UHFFFAOYSA-N 0.000 claims 1
- WJKWCYKKFLJBPU-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-[(1-methylimidazol-4-yl)methyl]morpholine-2-carboxamide Chemical compound CN1C=NC(CNC(=O)C2OCCN(C2)S(=O)(=O)C=2C3=CC(Br)=CC=C3NC=2C(N)=O)=C1 WJKWCYKKFLJBPU-UHFFFAOYSA-N 0.000 claims 1
- UNCPTNYTGPWAMP-YJJYDOSJSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-[(1r)-1-phenylethyl]morpholine-2-carboxamide Chemical compound C1([C@H](NC(=O)C2OCCN(C2)S(=O)(=O)C=2C3=CC(Br)=CC=C3NC=2C(N)=O)C)=CC=CC=C1 UNCPTNYTGPWAMP-YJJYDOSJSA-N 0.000 claims 1
- GDBDCTOXPBPDKS-MNNVXMFVSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-[(2s)-2-phenylcyclopropyl]morpholine-2-carboxamide Chemical compound C1([C@@H]2CC2NC(=O)C2OCCN(C2)S(=O)(=O)C=2C3=CC(Br)=CC=C3NC=2C(=O)N)=CC=CC=C1 GDBDCTOXPBPDKS-MNNVXMFVSA-N 0.000 claims 1
- FJFOELOCONHLKS-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-[(4-sulfamoylphenyl)methyl]morpholine-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N(C1)CCOC1C(=O)NCC1=CC=C(S(N)(=O)=O)C=C1 FJFOELOCONHLKS-UHFFFAOYSA-N 0.000 claims 1
- HMZQCQSQMQRPIT-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-[2-(cyclohexen-1-yl)ethyl]morpholine-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N(C1)CCOC1C(=O)NCCC1=CCCCC1 HMZQCQSQMQRPIT-UHFFFAOYSA-N 0.000 claims 1
- ATSDSCZNSHVCKY-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-[2-[(2,6-dichlorophenyl)methylsulfanyl]ethyl]morpholine-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N(C1)CCOC1C(=O)NCCSCC1=C(Cl)C=CC=C1Cl ATSDSCZNSHVCKY-UHFFFAOYSA-N 0.000 claims 1
- AAVXKPDLGJGJHS-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-[3-(2-methylpropoxy)propyl]morpholine-2-carboxamide Chemical compound C1COC(C(=O)NCCCOCC(C)C)CN1S(=O)(=O)C1=C(C(N)=O)NC2=CC=C(Br)C=C12 AAVXKPDLGJGJHS-UHFFFAOYSA-N 0.000 claims 1
- UVXVYDPJWKMBGF-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-[3-(2-oxopyrrolidin-1-yl)propyl]morpholine-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N(C1)CCOC1C(=O)NCCCN1CCCC1=O UVXVYDPJWKMBGF-UHFFFAOYSA-N 0.000 claims 1
- PGRDJYFVFQICLC-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-[6-(dimethylamino)hexyl]morpholine-2-carboxamide Chemical compound C1COC(C(=O)NCCCCCCN(C)C)CN1S(=O)(=O)C1=C(C(N)=O)NC2=CC=C(Br)C=C12 PGRDJYFVFQICLC-UHFFFAOYSA-N 0.000 claims 1
- ABOAHQAXVCCFCV-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-[[3-(trifluoromethyl)phenyl]methyl]morpholine-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N(C1)CCOC1C(=O)NCC1=CC=CC(C(F)(F)F)=C1 ABOAHQAXVCCFCV-UHFFFAOYSA-N 0.000 claims 1
- UINKAOQZCAISFP-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-[phenyl(pyridin-4-yl)methyl]morpholine-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N(C1)CCOC1C(=O)NC(C=1C=CN=CC=1)C1=CC=CC=C1 UINKAOQZCAISFP-UHFFFAOYSA-N 0.000 claims 1
- ZPONDIXPVUXHAO-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-cyclohexylmorpholine-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N(C1)CCOC1C(=O)NC1CCCCC1 ZPONDIXPVUXHAO-UHFFFAOYSA-N 0.000 claims 1
- HOQUYGRACWPBOK-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-methyl-n-[2-(4-methylphenoxy)ethyl]morpholine-2-carboxamide Chemical compound C1N(S(=O)(=O)C=2C3=CC(Br)=CC=C3NC=2C(N)=O)CCOC1C(=O)N(C)CCOC1=CC=C(C)C=C1 HOQUYGRACWPBOK-UHFFFAOYSA-N 0.000 claims 1
- WOAUJBAMOOGXHV-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-pentan-3-ylmorpholine-2-carboxamide Chemical compound C1COC(C(=O)NC(CC)CC)CN1S(=O)(=O)C1=C(C(N)=O)NC2=CC=C(Br)C=C12 WOAUJBAMOOGXHV-UHFFFAOYSA-N 0.000 claims 1
- JUUPVFRPVCRTSW-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-phenacylmorpholine-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N(C1)CCOC1C(=O)NCC(=O)C1=CC=CC=C1 JUUPVFRPVCRTSW-UHFFFAOYSA-N 0.000 claims 1
- RLIBDENUVWHRJO-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-phenylmorpholine-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N(C1)CCOC1C(=O)NC1=CC=CC=C1 RLIBDENUVWHRJO-UHFFFAOYSA-N 0.000 claims 1
- WIBCZRPQBXCQBH-UHFFFAOYSA-N 4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]morpholine-2-carboxamide Chemical compound C1COC(C(=O)N)CN1S(=O)(=O)C1=C(C(N)=O)NC2=CC=C(Br)C=C12 WIBCZRPQBXCQBH-UHFFFAOYSA-N 0.000 claims 1
- NVJOLLPMHBAUJS-UHFFFAOYSA-N 4-amino-5-bromo-3-morpholin-4-ylsulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C(N)=C2C=1S(=O)(=O)N1CCOCC1 NVJOLLPMHBAUJS-UHFFFAOYSA-N 0.000 claims 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims 1
- JETWKPNGGPAKAB-UHFFFAOYSA-N 5,6-dibromo-3-morpholin-4-ylsulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC(Br)=C(Br)C=C2C=1S(=O)(=O)N1CCOCC1 JETWKPNGGPAKAB-UHFFFAOYSA-N 0.000 claims 1
- QIWJLPQRYGZJEP-UHFFFAOYSA-N 5-(1-benzothiophen-3-yl)-3-morpholin-4-ylsulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(C=3C4=CC=CC=C4SC=3)C=C2C=1S(=O)(=O)N1CCOCC1 QIWJLPQRYGZJEP-UHFFFAOYSA-N 0.000 claims 1
- YNILYOFEDNJMLD-UHFFFAOYSA-N 5-(2-aminoethylamino)-3-morpholin-4-ylsulfonyl-1h-indole-2-carboxamide Chemical compound C12=CC(NCCN)=CC=C2NC(C(N)=O)=C1S(=O)(=O)N1CCOCC1 YNILYOFEDNJMLD-UHFFFAOYSA-N 0.000 claims 1
- JSPXXSMXGLDTSX-UHFFFAOYSA-N 5-(dimethylamino)-3-morpholin-4-ylsulfonyl-1h-indole-2-carboxamide Chemical compound C12=CC(N(C)C)=CC=C2NC(C(N)=O)=C1S(=O)(=O)N1CCOCC1 JSPXXSMXGLDTSX-UHFFFAOYSA-N 0.000 claims 1
- HZXVJSBYHUPQDU-UHFFFAOYSA-N 5-(furan-2-yl)-3-morpholin-4-ylsulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(C=3OC=CC=3)C=C2C=1S(=O)(=O)N1CCOCC1 HZXVJSBYHUPQDU-UHFFFAOYSA-N 0.000 claims 1
- VOQCRZDEHHXYKX-UHFFFAOYSA-N 5-(methanesulfonamido)-3-morpholin-4-ylsulfonyl-1h-indole-2-carboxamide Chemical compound C12=CC(NS(=O)(=O)C)=CC=C2NC(C(N)=O)=C1S(=O)(=O)N1CCOCC1 VOQCRZDEHHXYKX-UHFFFAOYSA-N 0.000 claims 1
- WHOZDFVSJSZSSN-UHFFFAOYSA-N 5-acetamido-3-morpholin-4-ylsulfonyl-1h-indole-2-carboxamide Chemical compound C12=CC(NC(=O)C)=CC=C2NC(C(N)=O)=C1S(=O)(=O)N1CCOCC1 WHOZDFVSJSZSSN-UHFFFAOYSA-N 0.000 claims 1
- GZFMJQTTWOVONY-UHFFFAOYSA-N 5-amino-3-morpholin-4-ylsulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(N)C=C2C=1S(=O)(=O)N1CCOCC1 GZFMJQTTWOVONY-UHFFFAOYSA-N 0.000 claims 1
- FOCNFEMBROJFGB-UHFFFAOYSA-N 5-bromo-3-(2,5-dihydroxypyrrol-1-yl)sulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N1C(O)=CC=C1O FOCNFEMBROJFGB-UHFFFAOYSA-N 0.000 claims 1
- XZWHILIZDVUPFX-UHFFFAOYSA-N 5-bromo-3-(3-hydroxyazetidin-1-yl)sulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N1CC(O)C1 XZWHILIZDVUPFX-UHFFFAOYSA-N 0.000 claims 1
- DUNKOXQLQCQHHZ-UHFFFAOYSA-N 5-bromo-3-(3-oxopiperazin-1-yl)sulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N1CCNC(=O)C1 DUNKOXQLQCQHHZ-UHFFFAOYSA-N 0.000 claims 1
- YAZODJZPIFLLJL-UHFFFAOYSA-N 5-bromo-3-(6-oxa-3-azabicyclo[3.1.0]hexan-3-ylsulfonyl)-1h-indole-2-carboxamide Chemical compound C1=C(Br)C=C2C(S(=O)(=O)N3CC4OC4C3)=C(C(=O)N)NC2=C1 YAZODJZPIFLLJL-UHFFFAOYSA-N 0.000 claims 1
- AODNHATWHNDXQC-OAHLLOKOSA-N 5-bromo-3-[(2r)-2-(phenoxymethyl)morpholin-4-yl]sulfonyl-1h-indole-2-carboxamide Chemical compound C([C@@H]1OCCN(C1)S(=O)(=O)C=1C2=CC(Br)=CC=C2NC=1C(=O)N)OC1=CC=CC=C1 AODNHATWHNDXQC-OAHLLOKOSA-N 0.000 claims 1
- YQWLEOKANCDUKG-UHFFFAOYSA-N 5-bromo-3-[(5-oxo-1,4-diazepan-1-yl)sulfonyl]-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N1CCNC(=O)CC1 YQWLEOKANCDUKG-UHFFFAOYSA-N 0.000 claims 1
- LLXLLVDSOIVRKW-UHFFFAOYSA-N 5-bromo-3-[2-(3,4-dihydro-1h-isoquinoline-2-carbonyl)morpholin-4-yl]sulfonyl-1h-indole-2-carboxamide Chemical compound C1CC2=CC=CC=C2CN1C(=O)C(C1)OCCN1S(=O)(=O)C1=C(C(=O)N)NC2=CC=C(Br)C=C21 LLXLLVDSOIVRKW-UHFFFAOYSA-N 0.000 claims 1
- CDSYGIYLLHGZJY-UHFFFAOYSA-N 5-bromo-3-[2-(3-phenylpyrrolidine-1-carbonyl)morpholin-4-yl]sulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N(C1)CCOC1C(=O)N(C1)CCC1C1=CC=CC=C1 CDSYGIYLLHGZJY-UHFFFAOYSA-N 0.000 claims 1
- DOYMOYNCEWNKDQ-UHFFFAOYSA-N 5-bromo-3-[2-(3-pyridin-4-ylpyrrolidine-1-carbonyl)morpholin-4-yl]sulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N(C1)CCOC1C(=O)N(C1)CCC1C1=CC=NC=C1 DOYMOYNCEWNKDQ-UHFFFAOYSA-N 0.000 claims 1
- SMUUUIVSZYKKSB-UHFFFAOYSA-N 5-bromo-3-[2-(4,4-diphenylpiperidine-1-carbonyl)morpholin-4-yl]sulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N(C1)CCOC1C(=O)N(CC1)CCC1(C=1C=CC=CC=1)C1=CC=CC=C1 SMUUUIVSZYKKSB-UHFFFAOYSA-N 0.000 claims 1
- BZKRKFHLMHOZGD-UHFFFAOYSA-N 5-bromo-3-[2-(4-hydroxy-4-phenylpiperidine-1-carbonyl)morpholin-4-yl]sulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N(C1)CCOC1C(=O)N(CC1)CCC1(O)C1=CC=CC=C1 BZKRKFHLMHOZGD-UHFFFAOYSA-N 0.000 claims 1
- NJVWMZKDSZHXJW-UHFFFAOYSA-N 5-bromo-3-[2-(thiomorpholine-4-carbonyl)morpholin-4-yl]sulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N(C1)CCOC1C(=O)N1CCSCC1 NJVWMZKDSZHXJW-UHFFFAOYSA-N 0.000 claims 1
- PSHAYXRUXUKNTI-UHFFFAOYSA-N 5-bromo-3-[2-[2-(2-phenylethyl)pyrrolidine-1-carbonyl]morpholin-4-yl]sulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N(C1)CCOC1C(=O)N1CCCC1CCC1=CC=CC=C1 PSHAYXRUXUKNTI-UHFFFAOYSA-N 0.000 claims 1
- ASDQBDNXDPOZKH-UHFFFAOYSA-N 5-bromo-3-[3-[[4-[(2-methylpropan-2-yl)oxy]phenyl]methyl]piperidin-1-yl]sulfonyl-1h-indole-2-carboxamide Chemical compound C1=CC(OC(C)(C)C)=CC=C1CC1CN(S(=O)(=O)C=2C3=CC(Br)=CC=C3NC=2C(N)=O)CCC1 ASDQBDNXDPOZKH-UHFFFAOYSA-N 0.000 claims 1
- YONQKLTYXRPVEL-UHFFFAOYSA-N 5-bromo-3-[4-(3-morpholin-4-ylpropyl)-3-oxopiperazin-1-yl]sulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N(CC1=O)CCN1CCCN1CCOCC1 YONQKLTYXRPVEL-UHFFFAOYSA-N 0.000 claims 1
- MOWQDJDLHYVTJL-UHFFFAOYSA-N 5-bromo-3-[4-(3-phenylpropyl)piperidin-1-yl]sulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N(CC1)CCC1CCCC1=CC=CC=C1 MOWQDJDLHYVTJL-UHFFFAOYSA-N 0.000 claims 1
- OVIHTMADCYPOFX-UHFFFAOYSA-N 5-bromo-3-[4-(4-bromophenyl)sulfonylpiperazin-1-yl]sulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N(CC1)CCN1S(=O)(=O)C1=CC=C(Br)C=C1 OVIHTMADCYPOFX-UHFFFAOYSA-N 0.000 claims 1
- LQMFKAMEDXQUMW-UHFFFAOYSA-N 5-bromo-3-[4-(4-methoxyphenyl)sulfonylpiperazin-1-yl]sulfonyl-1h-indole-2-carboxamide Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)N1CCN(S(=O)(=O)C=2C3=CC(Br)=CC=C3NC=2C(N)=O)CC1 LQMFKAMEDXQUMW-UHFFFAOYSA-N 0.000 claims 1
- BZIWURFOHDEPMV-UHFFFAOYSA-N 5-bromo-3-[4-[3-(dimethylamino)propyl]-3-oxopiperazin-1-yl]sulfonyl-1h-indole-2-carboxamide Chemical compound C1C(=O)N(CCCN(C)C)CCN1S(=O)(=O)C1=C(C(N)=O)NC2=CC=C(Br)C=C12 BZIWURFOHDEPMV-UHFFFAOYSA-N 0.000 claims 1
- DRMXOZZAMZBLAL-UHFFFAOYSA-N 5-bromo-3-morpholin-4-ylsulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N1CCOCC1 DRMXOZZAMZBLAL-UHFFFAOYSA-N 0.000 claims 1
- BEJXDWRINWBWHL-UHFFFAOYSA-N 5-bromo-3-morpholin-4-ylsulfonyl-4-nitro-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C([N+]([O-])=O)=C2C=1S(=O)(=O)N1CCOCC1 BEJXDWRINWBWHL-UHFFFAOYSA-N 0.000 claims 1
- HLMFSADZFTUGIV-UHFFFAOYSA-N 5-bromo-3-morpholin-4-ylsulfonyl-6-nitro-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC([N+]([O-])=O)=C(Br)C=C2C=1S(=O)(=O)N1CCOCC1 HLMFSADZFTUGIV-UHFFFAOYSA-N 0.000 claims 1
- JNDBPDZKQMBQPQ-UHFFFAOYSA-N 5-bromo-n-methoxy-n-methyl-3-[2-(phenoxymethyl)morpholin-4-yl]sulfonyl-1h-indole-2-carboxamide Chemical compound CON(C)C(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N(C1)CCOC1COC1=CC=CC=C1 JNDBPDZKQMBQPQ-UHFFFAOYSA-N 0.000 claims 1
- WGRLWGSSQQTENU-UHFFFAOYSA-N 5-chloro-3-(3,5-dihydro-2h-1,4-benzoxazepin-4-ylsulfonyl)-1h-indole-2-carboxamide Chemical compound C1COC2=CC=CC=C2CN1S(=O)(=O)C1=C(C(=O)N)NC2=CC=C(Cl)C=C21 WGRLWGSSQQTENU-UHFFFAOYSA-N 0.000 claims 1
- JQHPJDNDQSXBMJ-UHFFFAOYSA-N 5-chloro-3-(3-hydroxyazetidin-1-yl)sulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Cl)C=C2C=1S(=O)(=O)N1CC(O)C1 JQHPJDNDQSXBMJ-UHFFFAOYSA-N 0.000 claims 1
- QHTGJJRUCFONHZ-OAHLLOKOSA-N 5-chloro-3-[(2r)-2-(phenoxymethyl)morpholin-4-yl]sulfonyl-1h-indole-2-carboxamide Chemical compound C([C@@H]1OCCN(C1)S(=O)(=O)C=1C2=CC(Cl)=CC=C2NC=1C(=O)N)OC1=CC=CC=C1 QHTGJJRUCFONHZ-OAHLLOKOSA-N 0.000 claims 1
- QHTGJJRUCFONHZ-HNNXBMFYSA-N 5-chloro-3-[(2s)-2-(phenoxymethyl)morpholin-4-yl]sulfonyl-1h-indole-2-carboxamide Chemical compound C([C@H]1OCCN(C1)S(=O)(=O)C=1C2=CC(Cl)=CC=C2NC=1C(=O)N)OC1=CC=CC=C1 QHTGJJRUCFONHZ-HNNXBMFYSA-N 0.000 claims 1
- QHTGJJRUCFONHZ-UHFFFAOYSA-N 5-chloro-3-[2-(phenoxymethyl)morpholin-4-yl]sulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Cl)C=C2C=1S(=O)(=O)N(C1)CCOC1COC1=CC=CC=C1 QHTGJJRUCFONHZ-UHFFFAOYSA-N 0.000 claims 1
- ACLKTFWEGAHULM-UHFFFAOYSA-N 5-chloro-3-[2-[(2-ethoxyphenoxy)methyl]morpholin-4-yl]sulfonyl-1h-indole-2-carboxamide Chemical compound CCOC1=CC=CC=C1OCC1OCCN(S(=O)(=O)C=2C3=CC(Cl)=CC=C3NC=2C(N)=O)C1 ACLKTFWEGAHULM-UHFFFAOYSA-N 0.000 claims 1
- GBGSXVBDAMWTRA-UHFFFAOYSA-N 5-chloro-3-[2-[(4-chlorophenoxy)methyl]morpholin-4-yl]sulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Cl)C=C2C=1S(=O)(=O)N(C1)CCOC1COC1=CC=C(Cl)C=C1 GBGSXVBDAMWTRA-UHFFFAOYSA-N 0.000 claims 1
- XPJIPFZXYOKNBW-UHFFFAOYSA-N 5-chloro-3-[3-(2-methylphenyl)piperidin-1-yl]sulfonyl-1h-indole-2-carboxamide Chemical compound CC1=CC=CC=C1C1CN(S(=O)(=O)C=2C3=CC(Cl)=CC=C3NC=2C(N)=O)CCC1 XPJIPFZXYOKNBW-UHFFFAOYSA-N 0.000 claims 1
- AHFQFBRZCDNWQX-UHFFFAOYSA-N 5-chloro-3-[3-(2-phenylethyl)piperidin-1-yl]sulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Cl)C=C2C=1S(=O)(=O)N(C1)CCCC1CCC1=CC=CC=C1 AHFQFBRZCDNWQX-UHFFFAOYSA-N 0.000 claims 1
- OUWFQUPJYUZCMV-UHFFFAOYSA-N 5-chloro-3-[3-(2-phenylethyl)pyrrolidin-1-yl]sulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Cl)C=C2C=1S(=O)(=O)N(C1)CCC1CCC1=CC=CC=C1 OUWFQUPJYUZCMV-UHFFFAOYSA-N 0.000 claims 1
- SZOWNZFVZJXGJW-UHFFFAOYSA-N 5-chloro-3-[3-(4-methyl-1,2,4-triazol-3-yl)piperidin-1-yl]sulfonyl-1h-indole-2-carboxamide Chemical compound CN1C=NN=C1C1CN(S(=O)(=O)C=2C3=CC(Cl)=CC=C3NC=2C(N)=O)CCC1 SZOWNZFVZJXGJW-UHFFFAOYSA-N 0.000 claims 1
- TWRSWGBYNQHBOD-UHFFFAOYSA-N 5-chloro-3-[4-[2-(dimethylamino)ethyl]piperidin-1-yl]sulfonyl-1h-indole-2-carboxamide Chemical compound C1CC(CCN(C)C)CCN1S(=O)(=O)C1=C(C(N)=O)NC2=CC=C(Cl)C=C12 TWRSWGBYNQHBOD-UHFFFAOYSA-N 0.000 claims 1
- SKRXUYVDQGVYAN-UHFFFAOYSA-N 5-chloro-3-[4-[cyclopropyl-[3-(trifluoromethyl)phenyl]sulfonylamino]piperidin-1-yl]sulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Cl)C=C2C=1S(=O)(=O)N(CC1)CCC1N(S(=O)(=O)C=1C=C(C=CC=1)C(F)(F)F)C1CC1 SKRXUYVDQGVYAN-UHFFFAOYSA-N 0.000 claims 1
- NCDSMPZTIVZBEG-UHFFFAOYSA-N 5-chloro-3-[4-fluoro-4-(3-phenylpropyl)piperidin-1-yl]sulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Cl)C=C2C=1S(=O)(=O)N(CC1)CCC1(F)CCCC1=CC=CC=C1 NCDSMPZTIVZBEG-UHFFFAOYSA-N 0.000 claims 1
- XQFIPWLOHOORDP-UHFFFAOYSA-N 5-chloro-3-[4-hydroxy-4-(3-phenylpropyl)piperidin-1-yl]sulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Cl)C=C2C=1S(=O)(=O)N(CC1)CCC1(O)CCCC1=CC=CC=C1 XQFIPWLOHOORDP-UHFFFAOYSA-N 0.000 claims 1
- GVKSRJODGJJAFB-UHFFFAOYSA-N 5-chloro-3-[4-phenyl-4-(phenylmethoxymethyl)piperidin-1-yl]sulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Cl)C=C2C=1S(=O)(=O)N(CC1)CCC1(C=1C=CC=CC=1)COCC1=CC=CC=C1 GVKSRJODGJJAFB-UHFFFAOYSA-N 0.000 claims 1
- GJMCMIIWSHMNNM-RKDXNWHRSA-N 5-chloro-3-[[(1r,4r)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]sulfonyl]-1h-indole-2-carboxamide Chemical compound C1=C(Cl)C=C2C(S(=O)(=O)N3C[C@@]4(OC[C@@]3([H])C4)[H])=C(C(N)=O)NC2=C1 GJMCMIIWSHMNNM-RKDXNWHRSA-N 0.000 claims 1
- WOFUAHXUTHUPPJ-UHFFFAOYSA-N 5-chloro-3-morpholin-4-ylsulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Cl)C=C2C=1S(=O)(=O)N1CCOCC1 WOFUAHXUTHUPPJ-UHFFFAOYSA-N 0.000 claims 1
- JVVFBUHVMQMIKV-UHFFFAOYSA-N 5-chloro-3-piperazin-1-ylsulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Cl)C=C2C=1S(=O)(=O)N1CCNCC1 JVVFBUHVMQMIKV-UHFFFAOYSA-N 0.000 claims 1
- IIKOJGNAKMBGRW-UHFFFAOYSA-N 5-chloro-3-piperidin-1-ylsulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Cl)C=C2C=1S(=O)(=O)N1CCCCC1 IIKOJGNAKMBGRW-UHFFFAOYSA-N 0.000 claims 1
- DARVQYMHLCLCKU-UHFFFAOYSA-N 5-chloro-3-pyrrolidin-1-ylsulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Cl)C=C2C=1S(=O)(=O)N1CCCC1 DARVQYMHLCLCKU-UHFFFAOYSA-N 0.000 claims 1
- DHSOHPSFQCSLSO-UHFFFAOYSA-N 5-chloro-3-thiomorpholin-4-ylsulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Cl)C=C2C=1S(=O)(=O)N1CCSCC1 DHSOHPSFQCSLSO-UHFFFAOYSA-N 0.000 claims 1
- KQERZVUWFQKZNY-UHFFFAOYSA-N 5-ethenyl-3-morpholin-4-ylsulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(C=C)C=C2C=1S(=O)(=O)N1CCOCC1 KQERZVUWFQKZNY-UHFFFAOYSA-N 0.000 claims 1
- FYNRLMPZMCGLPK-UHFFFAOYSA-N 5-ethoxy-3-morpholin-4-ylsulfonyl-1h-indole-2-carboxamide Chemical compound C12=CC(OCC)=CC=C2NC(C(N)=O)=C1S(=O)(=O)N1CCOCC1 FYNRLMPZMCGLPK-UHFFFAOYSA-N 0.000 claims 1
- OLEMTEFQAJKDOD-UHFFFAOYSA-N 5-ethyl-3-morpholin-4-ylsulfonyl-1h-indole-2-carboxamide Chemical compound C12=CC(CC)=CC=C2NC(C(N)=O)=C1S(=O)(=O)N1CCOCC1 OLEMTEFQAJKDOD-UHFFFAOYSA-N 0.000 claims 1
- SYFFJJNZWRFINC-OAHLLOKOSA-N 5-fluoro-3-[(2r)-2-(phenoxymethyl)morpholin-4-yl]sulfonyl-1h-indole-2-carboxamide Chemical compound C([C@@H]1OCCN(C1)S(=O)(=O)C=1C2=CC(F)=CC=C2NC=1C(=O)N)OC1=CC=CC=C1 SYFFJJNZWRFINC-OAHLLOKOSA-N 0.000 claims 1
- IGULJPOZKYHQPW-UHFFFAOYSA-N 5-formyl-3-morpholin-4-ylsulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(C=O)C=C2C=1S(=O)(=O)N1CCOCC1 IGULJPOZKYHQPW-UHFFFAOYSA-N 0.000 claims 1
- ALPHUMDABZFTFC-UHFFFAOYSA-N 5-hexyl-3-morpholin-4-ylsulfonyl-1h-indole-2-carboxamide Chemical compound C12=CC(CCCCCC)=CC=C2NC(C(N)=O)=C1S(=O)(=O)N1CCOCC1 ALPHUMDABZFTFC-UHFFFAOYSA-N 0.000 claims 1
- AXKWAKYXXCJBNM-UHFFFAOYSA-N 5-hydroxy-3-morpholin-4-ylsulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(O)C=C2C=1S(=O)(=O)N1CCOCC1 AXKWAKYXXCJBNM-UHFFFAOYSA-N 0.000 claims 1
- RHLCVZXMPSPSHQ-OAHLLOKOSA-N 5-iodo-3-[(2r)-2-(phenoxymethyl)morpholin-4-yl]sulfonyl-1h-indole-2-carboxamide Chemical compound C([C@@H]1OCCN(C1)S(=O)(=O)C=1C2=CC(I)=CC=C2NC=1C(=O)N)OC1=CC=CC=C1 RHLCVZXMPSPSHQ-OAHLLOKOSA-N 0.000 claims 1
- RHLCVZXMPSPSHQ-UHFFFAOYSA-N 5-iodo-3-[2-(phenoxymethyl)morpholin-4-yl]sulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(I)C=C2C=1S(=O)(=O)N(C1)CCOC1COC1=CC=CC=C1 RHLCVZXMPSPSHQ-UHFFFAOYSA-N 0.000 claims 1
- GKIQFBOQZMCUKR-UHFFFAOYSA-N 5-iodo-3-morpholin-4-ylsulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(I)C=C2C=1S(=O)(=O)N1CCOCC1 GKIQFBOQZMCUKR-UHFFFAOYSA-N 0.000 claims 1
- NKFVQWXRTZPDEH-UHFFFAOYSA-N 5-methoxy-3-morpholin-4-ylsulfonyl-1h-indole-2-carboxamide Chemical compound C12=CC(OC)=CC=C2NC(C(N)=O)=C1S(=O)(=O)N1CCOCC1 NKFVQWXRTZPDEH-UHFFFAOYSA-N 0.000 claims 1
- VVMSYJGTEMWDAY-UHFFFAOYSA-N 5-methyl-3-morpholin-4-ylsulfonyl-1h-indole-2-carboxamide Chemical compound C12=CC(C)=CC=C2NC(C(N)=O)=C1S(=O)(=O)N1CCOCC1 VVMSYJGTEMWDAY-UHFFFAOYSA-N 0.000 claims 1
- ROTBUTOGKCOION-UHFFFAOYSA-N 5-methylsulfonyl-3-morpholin-4-ylsulfonyl-1h-indole-2-carboxamide Chemical compound C12=CC(S(=O)(=O)C)=CC=C2NC(C(N)=O)=C1S(=O)(=O)N1CCOCC1 ROTBUTOGKCOION-UHFFFAOYSA-N 0.000 claims 1
- JRRCLXSUKXYBLM-UHFFFAOYSA-N 6-amino-5-bromo-3-morpholin-4-ylsulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC(N)=C(Br)C=C2C=1S(=O)(=O)N1CCOCC1 JRRCLXSUKXYBLM-UHFFFAOYSA-N 0.000 claims 1
- CKDUOEOKHJDPJK-UHFFFAOYSA-N 6-bromo-3-morpholin-4-ylsulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC(Br)=CC=C2C=1S(=O)(=O)N1CCOCC1 CKDUOEOKHJDPJK-UHFFFAOYSA-N 0.000 claims 1
- LTYVOGWHUDDOHQ-UHFFFAOYSA-N 6-bromo-7-(dimethylamino)-3-morpholin-4-ylsulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC=2C(N(C)C)=C(Br)C=CC=2C=1S(=O)(=O)N1CCOCC1 LTYVOGWHUDDOHQ-UHFFFAOYSA-N 0.000 claims 1
- LBWLNHBDPKPRGK-UHFFFAOYSA-N 6-hydroxy-3-morpholin-4-ylsulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC(O)=CC=C2C=1S(=O)(=O)N1CCOCC1 LBWLNHBDPKPRGK-UHFFFAOYSA-N 0.000 claims 1
- GBPOHXHMLIHJGG-UHFFFAOYSA-N 6-methoxy-3-morpholin-4-ylsulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=CC(OC)=CC=C2C=1S(=O)(=O)N1CCOCC1 GBPOHXHMLIHJGG-UHFFFAOYSA-N 0.000 claims 1
- QBGUTIIJMCNFEI-UHFFFAOYSA-N 7-(aminomethyl)-3-morpholin-4-ylsulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC=2C(CN)=CC=CC=2C=1S(=O)(=O)N1CCOCC1 QBGUTIIJMCNFEI-UHFFFAOYSA-N 0.000 claims 1
- LYWIXBACQLUGMR-NRFANRHFSA-N 7-(benzylamino)-3-[(2s)-2-(phenoxymethyl)morpholin-4-yl]sulfonyl-1h-indole-2-carboxamide Chemical compound C1=CC=C2C(S(=O)(=O)N3C[C@@H](COC=4C=CC=CC=4)OCC3)=C(C(=O)N)NC2=C1NCC1=CC=CC=C1 LYWIXBACQLUGMR-NRFANRHFSA-N 0.000 claims 1
- OXQVWAXWGBRBRW-UHFFFAOYSA-N 7-(methanesulfonamido)-3-morpholin-4-ylsulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC=2C(NS(=O)(=O)C)=CC=CC=2C=1S(=O)(=O)N1CCOCC1 OXQVWAXWGBRBRW-UHFFFAOYSA-N 0.000 claims 1
- WIJZDMQVPXWGTD-UHFFFAOYSA-N 7-[(2-chloropyridin-4-yl)methylamino]-3-morpholin-4-ylsulfonyl-1h-indole-2-carboxamide Chemical compound C1=CC=C2C(S(=O)(=O)N3CCOCC3)=C(C(=O)N)NC2=C1NCC1=CC=NC(Cl)=C1 WIJZDMQVPXWGTD-UHFFFAOYSA-N 0.000 claims 1
- ZGPBLVQKFQBEHF-UHFFFAOYSA-N 7-acetamido-3-morpholin-4-ylsulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC=2C(NC(=O)C)=CC=CC=2C=1S(=O)(=O)N1CCOCC1 ZGPBLVQKFQBEHF-UHFFFAOYSA-N 0.000 claims 1
- HSPKCBMJTFQLNE-AWEZNQCLSA-N 7-amino-3-[(2s)-2-(phenoxymethyl)morpholin-4-yl]sulfonyl-1h-indole-2-carboxamide Chemical compound C([C@H]1OCCN(C1)S(=O)(=O)C=1C2=CC=CC(N)=C2NC=1C(=O)N)OC1=CC=CC=C1 HSPKCBMJTFQLNE-AWEZNQCLSA-N 0.000 claims 1
- KHXHDBNAAPLQCZ-UHFFFAOYSA-N 7-amino-3-morpholin-4-ylsulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=C(N)C=CC=C2C=1S(=O)(=O)N1CCOCC1 KHXHDBNAAPLQCZ-UHFFFAOYSA-N 0.000 claims 1
- ONNUBPUALGCWJW-UHFFFAOYSA-N 7-amino-4,6-dibromo-3-morpholin-4-ylsulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=C(N)C(Br)=CC(Br)=C2C=1S(=O)(=O)N1CCOCC1 ONNUBPUALGCWJW-UHFFFAOYSA-N 0.000 claims 1
- LRPQSKNSBHZKEO-UHFFFAOYSA-N 7-amino-6-bromo-3-morpholin-4-ylsulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=C(N)C(Br)=CC=C2C=1S(=O)(=O)N1CCOCC1 LRPQSKNSBHZKEO-UHFFFAOYSA-N 0.000 claims 1
- MPBCZUKPXXWTFJ-UHFFFAOYSA-N 7-chloro-3-morpholin-4-ylsulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=C(Cl)C=CC=C2C=1S(=O)(=O)N1CCOCC1 MPBCZUKPXXWTFJ-UHFFFAOYSA-N 0.000 claims 1
- ZQPHGZKIOSVSSN-UHFFFAOYSA-N 7-cyano-3-morpholin-4-ylsulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC2=C(C#N)C=CC=C2C=1S(=O)(=O)N1CCOCC1 ZQPHGZKIOSVSSN-UHFFFAOYSA-N 0.000 claims 1
- RDGLESUJJAWONG-UHFFFAOYSA-N 7-methylsulfinyl-3-morpholin-4-ylsulfonyl-1h-indole-2-carboxamide Chemical compound NC(=O)C=1NC=2C(S(=O)C)=CC=CC=2C=1S(=O)(=O)N1CCOCC1 RDGLESUJJAWONG-UHFFFAOYSA-N 0.000 claims 1
- GRTHUZVHLJVYNF-AWEZNQCLSA-N 7-nitro-3-[(2s)-2-(phenoxymethyl)morpholin-4-yl]sulfonyl-1h-indole-2-carboxamide Chemical compound C([C@H]1OCCN(C1)S(=O)(=O)C=1C2=CC=CC(=C2NC=1C(=O)N)[N+]([O-])=O)OC1=CC=CC=C1 GRTHUZVHLJVYNF-AWEZNQCLSA-N 0.000 claims 1
- WBYWJNBOPHWVBK-RKDXNWHRSA-N ClC=1C=C2C(=C(NC2=CC1)C(=O)N)S(=O)(=O)N1C[C@H](O[C@@H](C1)C)C Chemical compound ClC=1C=C2C(=C(NC2=CC1)C(=O)N)S(=O)(=O)N1C[C@H](O[C@@H](C1)C)C WBYWJNBOPHWVBK-RKDXNWHRSA-N 0.000 claims 1
- 150000003857 carboxamides Chemical class 0.000 claims 1
- HGSYKXLOULTAOS-UHFFFAOYSA-N ethyl 1-[1-[(2-carbamoyl-5-chloro-1h-indol-3-yl)sulfonyl]piperidin-4-yl]piperidine-3-carboxylate Chemical compound C1C(C(=O)OCC)CCCN1C1CCN(S(=O)(=O)C=2C3=CC(Cl)=CC=C3NC=2C(N)=O)CC1 HGSYKXLOULTAOS-UHFFFAOYSA-N 0.000 claims 1
- 125000002912 morpholin-4-ylsulfonyl group Chemical group O1C([H])([H])C([H])([H])N(S(=O)(=O)[*])C([H])([H])C1([H])[H] 0.000 claims 1
- IPEWLENLQPVAES-UHFFFAOYSA-N n-(1h-benzimidazol-2-ylmethyl)-4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]morpholine-2-carboxamide Chemical compound C1=CC=C2NC(CNC(=O)C3OCCN(C3)S(=O)(=O)C=3C4=CC(Br)=CC=C4NC=3C(=O)N)=NC2=C1 IPEWLENLQPVAES-UHFFFAOYSA-N 0.000 claims 1
- IXKSJYPXPZGGNO-UHFFFAOYSA-N n-benzhydryl-4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]morpholine-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N(C1)CCOC1C(=O)NC(C=1C=CC=CC=1)C1=CC=CC=C1 IXKSJYPXPZGGNO-UHFFFAOYSA-N 0.000 claims 1
- UKCNMUDVTWOHHH-UHFFFAOYSA-N n-benzyl-4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]-n-methylmorpholine-2-carboxamide Chemical compound C1N(S(=O)(=O)C=2C3=CC(Br)=CC=C3NC=2C(N)=O)CCOC1C(=O)N(C)CC1=CC=CC=C1 UKCNMUDVTWOHHH-UHFFFAOYSA-N 0.000 claims 1
- PYVOYTNMHYKHMU-UHFFFAOYSA-N n-benzyl-4-[(5-bromo-2-carbamoyl-1h-indol-3-yl)sulfonyl]morpholine-2-carboxamide Chemical compound NC(=O)C=1NC2=CC=C(Br)C=C2C=1S(=O)(=O)N(C1)CCOC1C(=O)NCC1=CC=CC=C1 PYVOYTNMHYKHMU-UHFFFAOYSA-N 0.000 claims 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims 1
- 0 CC=C=Cc1c2c(S(**)(=O)=O)c(C(*)=O)[n]c2ccc1 Chemical compound CC=C=Cc1c2c(S(**)(=O)=O)c(C(*)=O)[n]c2ccc1 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40247802P | 2002-08-09 | 2002-08-09 | |
| US60/402,478 | 2002-08-09 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004527799A Division JP4332112B2 (ja) | 2002-08-09 | 2003-08-05 | チロシンキナーゼ阻害薬 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009221205A JP2009221205A (ja) | 2009-10-01 |
| JP2009221205A5 true JP2009221205A5 (https=) | 2009-11-26 |
| JP5261275B2 JP5261275B2 (ja) | 2013-08-14 |
Family
ID=31715862
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004527799A Expired - Fee Related JP4332112B2 (ja) | 2002-08-09 | 2003-08-05 | チロシンキナーゼ阻害薬 |
| JP2009110392A Expired - Fee Related JP5261275B2 (ja) | 2002-08-09 | 2009-04-30 | チロシンキナーゼ阻害薬 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004527799A Expired - Fee Related JP4332112B2 (ja) | 2002-08-09 | 2003-08-05 | チロシンキナーゼ阻害薬 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7560546B2 (https=) |
| EP (1) | EP1534695B1 (https=) |
| JP (2) | JP4332112B2 (https=) |
| AT (1) | ATE482938T1 (https=) |
| AU (1) | AU2003261415C1 (https=) |
| CA (1) | CA2494962C (https=) |
| DE (1) | DE60334386D1 (https=) |
| WO (1) | WO2004014851A2 (https=) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004014851A2 (en) * | 2002-08-09 | 2004-02-19 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
| US20060128783A1 (en) * | 2002-08-09 | 2006-06-15 | Dinsmore Christopher J | Tyrosine kinase inhibitors |
| SE0302811D0 (sv) * | 2003-10-23 | 2003-10-23 | Astrazeneca Ab | Novel compounds |
| JO2724B1 (en) | 2004-08-19 | 2013-09-15 | افينتس فارماسوتيكالز انك | 3-Alternative-5 -6-Amino Alkyl Indole-2-Carboxyl Acid Amide and Related Isotopes as Casein Kinase Inhibitors |
| EP2308839B1 (en) | 2005-04-20 | 2017-03-01 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compounds |
| CA2612554A1 (en) * | 2005-06-28 | 2007-01-04 | Merck & Co., Inc. | Non-nucleoside reverse transcriptase inhibitors |
| NZ563687A (en) * | 2005-06-30 | 2011-07-29 | Smithkline Beecham Corp | 3-[1-(ethylsulfonyl)-4-piperidinyl]-5-[2-(1-methylethyl)-2,3-dihydro-1H-isoindol-5-yl]-1H-indole-7-carboxamide for inhibiting IKK2 (aka IKKbeta) |
| US20090131494A1 (en) * | 2005-08-11 | 2009-05-21 | Williams Theresa M | Non-Nucleoside Reverse Transcriptase Inhibitors |
| WO2008108445A1 (ja) | 2007-03-07 | 2008-09-12 | Takeda Pharmaceutical Company Limited | ベンゾオキサゼピン誘導体およびその用途 |
| US8642067B2 (en) | 2007-04-02 | 2014-02-04 | Allergen, Inc. | Methods and compositions for intraocular administration to treat ocular conditions |
| WO2010118063A2 (en) | 2009-04-06 | 2010-10-14 | Agios Pharmaceuticals, Inc. | Therapeutic compositions and related methods of use |
| WO2010138490A1 (en) * | 2009-05-26 | 2010-12-02 | Exelixis, Inc. | Benzoxazepines as inhibitors of mtor and methods of their use and manufacture |
| ES2618630T3 (es) | 2009-06-29 | 2017-06-21 | Agios Pharmaceuticals, Inc. | Composiciones terapéuticas y métodos de uso relacionados |
| RU2561132C2 (ru) | 2009-06-29 | 2015-08-20 | Аджиос Фармасьютикалз, Инк. | Производные хинолинсульфонамидов и их применение для модулирования пкм2 активности |
| CA2821975A1 (en) | 2010-12-17 | 2012-06-21 | Shunqi Yan | N-(4-(azetidine-1-carbonyl)phenyl)-(hetero-) arylsulfonamide derivatives as pyruvate kinase m2 pkm2 modulators |
| WO2012088314A1 (en) | 2010-12-21 | 2012-06-28 | Agios Pharmaceuticals, Inc. | Bicyclic pkm2 activators |
| TWI549947B (zh) | 2010-12-29 | 2016-09-21 | 阿吉歐斯製藥公司 | 治療化合物及組成物 |
| WO2012143879A1 (en) * | 2011-04-21 | 2012-10-26 | Piramal Healthcare Limited | A crystalline form of a salt of a morpholino sulfonyl indole derivative and a process for its preparation |
| WO2012151440A1 (en) | 2011-05-03 | 2012-11-08 | Agios Pharmaceuticals, Inc. | Pyruvate kinase activators for use for increasing lifetime of the red blood cells and treating anemia |
| SG194697A1 (en) | 2011-05-03 | 2013-12-30 | Agios Pharmaceuticals Inc | Pyruvate kinase activators for use in therapy |
| US8748446B2 (en) | 2012-03-03 | 2014-06-10 | Nanoquantum Sciences, Inc. | Halogenated compounds for photodynamic therapy |
| WO2013148227A1 (en) * | 2012-03-28 | 2013-10-03 | Merck Sharp & Dohme Corp. | Insulin-like growth factor-1 receptor inhibitors |
| US20140303121A1 (en) | 2013-03-15 | 2014-10-09 | Plexxikon Inc. | Heterocyclic compounds and uses thereof |
| SG11201506687RA (en) | 2013-03-15 | 2015-09-29 | Plexxikon Inc | Heterocyclic compounds and uses thereof |
| WO2014139144A1 (en) | 2013-03-15 | 2014-09-18 | Agios Pharmaceuticals, Inc. | Therapeutic compounds and compositions |
| FI3307271T3 (fi) | 2015-06-11 | 2023-10-17 | Agios Pharmaceuticals Inc | Pyruvaattikinaasin aktivaattorien käyttämisen menetelmä |
| JP7675519B2 (ja) | 2017-10-13 | 2025-05-13 | オプナ バイオ ソシエテ アノニム | キナーゼを調節するための化合物の固体形態 |
| TW202411219A (zh) * | 2022-06-02 | 2024-03-16 | 大陸商西藏海思科製藥有限公司 | 雜環化合物ccr4抑制劑及其用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3209011A (en) * | 1963-10-07 | 1965-09-28 | Upjohn Co | 3-[(alkylcarbamoyl) sulfamoyl]-1-alkylindole-2-carboxylic acids and esters thereof |
| FR1410699A (fr) | 1963-10-07 | 1965-09-10 | Upjohn Co | Nouveaux indols |
| US3180875A (en) * | 1963-10-07 | 1965-04-27 | Upjohn Co | Derivatives of 3, 3'-dithiobis[indole-2-carboxylic acid] dihydrazides |
| BR8204028A (pt) | 1981-07-16 | 1983-07-05 | Du Pont | Composto herbicida composicao adequada e processo para controlar o crescimento de vegetacao indesejada |
| US5527819A (en) * | 1991-09-06 | 1996-06-18 | Merck & Co., Inc. | Inhibitors of HIV reverse transcriptase |
| HUT74614A (en) * | 1993-02-24 | 1997-01-28 | Merck & Co Inc | Nindol derivates suitable for treatment of infection by hiv and pharmaceutical compositions containing them |
| HUP9802034A3 (en) | 1995-04-04 | 2000-04-28 | Encysive Pharmaceuticals Inc H | Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin and use of the compounds |
| EP0984930B1 (en) * | 1997-05-07 | 2005-04-06 | Sugen, Inc. | 2-indolinone derivatives as modulators of protein kinase activity |
| GB9902455D0 (en) * | 1999-02-05 | 1999-03-24 | Zeneca Ltd | Chemical compounds |
| US7129225B2 (en) | 2001-10-22 | 2006-10-31 | The Research Foundation Of State University Of New York | Protection against and treatment of hearing loss |
| WO2004014851A2 (en) * | 2002-08-09 | 2004-02-19 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
| US20060128783A1 (en) * | 2002-08-09 | 2006-06-15 | Dinsmore Christopher J | Tyrosine kinase inhibitors |
-
2003
- 2003-08-05 WO PCT/US2003/024643 patent/WO2004014851A2/en not_active Ceased
- 2003-08-05 AU AU2003261415A patent/AU2003261415C1/en not_active Ceased
- 2003-08-05 AT AT03784961T patent/ATE482938T1/de not_active IP Right Cessation
- 2003-08-05 JP JP2004527799A patent/JP4332112B2/ja not_active Expired - Fee Related
- 2003-08-05 DE DE60334386T patent/DE60334386D1/de not_active Expired - Lifetime
- 2003-08-05 US US10/523,285 patent/US7560546B2/en not_active Expired - Lifetime
- 2003-08-05 CA CA2494962A patent/CA2494962C/en not_active Expired - Fee Related
- 2003-08-05 EP EP03784961A patent/EP1534695B1/en not_active Expired - Lifetime
-
2009
- 2009-02-13 US US12/378,473 patent/US20090186871A1/en not_active Abandoned
- 2009-04-30 JP JP2009110392A patent/JP5261275B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009221205A5 (https=) | ||
| CA2494962A1 (en) | Tyrosine kinase inhibitors | |
| JP4684229B2 (ja) | ヘテロアリール置換された１，３−ジヒドロインドール−２−オン誘導体および該誘導体を含有する医薬品 | |
| RU2482111C2 (ru) | Соединения, обладающие противораковой активностью | |
| JP2013517273A5 (https=) | ||
| RU2009103313A (ru) | Индолы в качестве модуляторов 5-нт6 | |
| AU732863B2 (en) | Indole derivatives having combined 5HT1A, 5HT1B and 5HT1D receptor antagonist activity | |
| PE20090717A1 (es) | Derivados de quinolina como inhibidores de la pi3 quinasa | |
| JP2006500348A5 (https=) | ||
| JP2013544840A5 (https=) | ||
| JP2010513304A5 (https=) | ||
| JP2004509953A5 (https=) | ||
| RU2006129492A (ru) | Производные индола и их применение в качестве ингибиторов киназ, в частности, ингибиторов ikk2 | |
| US20040127536A1 (en) | Methods for treating an inflammatory condition or inhibiting JNK | |
| RU2010137114A (ru) | Амидные производные как позитивные аллостерические модуляторы и способы их применения | |
| JP2010529991A5 (https=) | ||
| RU2006117635A (ru) | Производные индолинона и их применение для лечения патологических состояний, таких как злокачественное новообразование | |
| JP2007516173A5 (https=) | ||
| PE20080944A1 (es) | Derivados de pirimidina como inhibidores del receptor de cinasa activina(alk-5) | |
| JP2006505522A5 (https=) | ||
| RU2013133800A (ru) | Селективные к bcl-2 агенты, вызывающие апоптоз, для лечения рака и иммунных заболеваний | |
| JP2004521087A5 (https=) | ||
| JP2005531501A5 (https=) | ||
| CN1345318A (zh) | 与多巴胺d3受体具有亲和力的三唑化合物 | |
| JP2007531757A5 (https=) |